02-17-2016, 10:43 AM
(02-17-2016, 10:07 AM)DividendGarden Wrote: Dr. Pepper Snapple (DPS) is one of my largest holdings, and I've had it for many years. This morning they reported earnings, but gave "weak" guidance for 2016, although it was still positive growth and I didn't view it as weak. Just wondering if anyone had thoughts. Bought back 3% of outstanding shares, margins expanded, lots of growth across the board. I still feel great about DPS and will continue to DRIP as I have for many years.DPS is a great company and one of those that will work for 2016-2017 with the turmoil in the market and slowdown. I have it on my buy list of we should get to $88. In the last month I have bought JNJ, PEP, KR, RAI, MMM and SYY which are all my largest holdings. You see a pattern here LOL. The other stocks I bought were AXP, DIS, CMI and XON because they were of great value and pay a nice dividend. GL with DPS
Dr Pepper Snapple (NYSE:DPS): Q4 EPS of $1.00 beats by $0.02.
Revenue of $1.55B (+2.6% Y/Y) beats by $20M.
FY2016 Guidance: Net sales: ~+1%; Core EPS: $4.20 to $4.30; Core tax rate: ~35.5%; Capex: ~3% of net sales.
http://seekingalpha.com/pr/16209956-dr-pepper-snapple-group-reports-fourth-quarter-full-year-2015-results